Literature DB >> 10725790

The regulatory role of MRP8 (S100A8) and MRP14 (S100A9) in the transendothelial migration of human leukocytes.

C Kerkhoff1, I Eue, C Sorg.   

Abstract

The hallmark of developing inflammatory lesions is the excess migration of recruited phagocytes together with the enhanced cell surface expression of adhesion molecules. Recent investigations give evidence that the two myeloid-related proteins MRP8 (S100A8) and MRP14 (S100A9), which are abundant in activated or recruited phagocytes, may have a modulatory role in inflammatory responses. S100A9 displays a regulatory role in the transendothelial migration of human monocytes, and the secreted S100A8/A9 complex may serve as a transport protein to move arachidonic acid to its target cells. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10725790     DOI： 10.1159/000028098

Source DB:  PubMed          Journal:  Pathobiology        ISSN： 1015-2008            Impact factor:   4.342


  14 in total

1.  CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis.

Authors:  Maria Lampinen; Amanda Waddell; Richard Ahrens; Marie Carlson; Simon P Hogan
Journal:  J Leukoc Biol       Date:  2013-07-31       Impact factor: 4.962

2.  An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes.

Authors:  G Bouma; J M C Coppens; W-K Lam-Tse; W Luini; K Sintnicolaas; W H Levering; S Sozzani; H A Drexhage; M A Versnel
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

3.  S-glutathionylation regulates inflammatory activities of S100A9.

Authors:  Su Yin Lim; Mark J Raftery; Jesse Goyette; Carolyn L Geczy
Journal:  J Biol Chem       Date:  2010-03-11       Impact factor: 5.157

4.  Myeloid-related protein-8/14 is critical for the biological response to vascular injury.

Authors:  Kevin Croce; Huiyun Gao; Yunmei Wang; Toshifumi Mooroka; Masashi Sakuma; Can Shi; Galina K Sukhova; René R S Packard; Nancy Hogg; Peter Libby; Daniel I Simon
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

5.  Myoloid-related protein 8, an endogenous ligand of Toll-like receptor 4, is involved in epileptogenesis of mesial temporal lobe epilepsy via activation of the nuclear factor-κB pathway in astrocytes.

Authors:  Na Gan; Lifen Yang; Ahmed Omran; Jing Peng; Liwen Wu; Fang He; Ciliu Zhang; Qiulian Xiang; Huimin Kong; Yupin Ma; Muhammad Usman Ashhab; Xiaolu Deng; Fei Yin
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

6.  Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis.

Authors:  Julie A Wolfram; Doina Diaconu; Denise A Hatala; Jessica Rastegar; Dorothy A Knutsen; Abigail Lowther; David Askew; Anita C Gilliam; Thomas S McCormick; Nicole L Ward
Journal:  Am J Pathol       Date:  2009-04       Impact factor: 4.307

7.  Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.

Authors:  Jim Dimitroulakos; Wilson H Marhin; Jason Tokunaga; Jonathan Irish; Patrick Gullane; Linda Z Penn; Suzanne Kamel-Reid
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

8.  Intestinal CCL11 and eosinophilic inflammation is regulated by myeloid cell-specific RelA/p65 in mice.

Authors:  Amanda Waddell; Richard Ahrens; Yi-Ting Tsai; Joseph D Sherrill; Lee A Denson; Kris A Steinbrecher; Simon P Hogan
Journal:  J Immunol       Date:  2013-04-05       Impact factor: 5.422

9.  Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro.

Authors:  Marie-Pierre Manitz; Basil Horst; Stephan Seeliger; Anke Strey; Boris V Skryabin; Matthias Gunzer; Werner Frings; Frank Schönlau; Johannes Roth; Clemens Sorg; Wolfgang Nacken
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

10.  Myeloid-related protein-14 regulates deep vein thrombosis.

Authors:  Yunmei Wang; Huiyun Gao; Chase W Kessinger; Alvin Schmaier; Farouc A Jaffer; Daniel I Simon
Journal:  JCI Insight       Date:  2017-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.